Endo Pharmaceuticals (ENDP) agreed to buy generics company Qualitest Pharmaceuticals for $1.2 billion cash.
Qualitest is the sixth-largest U.S. generics company as measured by prescriptions filled. Qualitest will add about $400 million to Endo’s annual revenue and 40 cents per share in annual adjusted earnings, Endo said in a statement.
Sponsored Links
“We believe that this transaction will…
Continue reading Endo to Acquire Generics Company Qualitest for $1.2 Billion
Endo to Acquire Generics Company Qualitest for $1.2 Billion originally appeared on DailyFinance on Tue, 28 Sep 2010 06:31:00.
Filed Under: Company News, Health Care, Retail